Press Releases

There are two new junior research groups at the German Centre for Cardiovascular Research (DZHK). The DZHK was able to successfully recruit their leaders from the US: Dr. Nuno Guimarães Camboa previously carried out research at the University of California and is now coming to...

Jeanette Erdmann (DZHK partner site Hamburg/Kiel/Lübeck), Michael Joner and Heribert Schunkert (both DZHK partner site Munich) are members of a consortium which is supported by the French-American Leducq Foundation with six million dollars.

If several coronary vessels are dangerously narrowed, patients are often treated with a bypass operation. In other words, vascular grafts are fashioned that redirect vital oxygenated blood around the blocked sections to the heart. The patients’ veins are often used as bypass...

Scientists of the Charité – Universitätsmedizin Berlin are investigating a new concept for the treatment of heart failure in a study of the German Centre for Cardiovascular Research (DZHK). They want to treat the impaired energy metabolism in patients with heart failure and...

How new blood vessels are formed in mammals, for example, during development or after an injury, was previously not precisely known. Scientists of the German Centre for Cardiovascular Research (DZHK) were now able to shed light on this process. They demonstrated that individual...

A study led by scientists of the German Centre for Cardiovascular Research (DZHK) at the Rhine-Main partner site found that the risk of major adverse cardiac events in patients with coronary artery disease can be substantially better assessed with a short MRI examination than...

Recently, all 17 hospitals that are members of the German Centre for Cardiovascular Research (DZHK) have had cardiovascular clinical research units at their disposal. These units that have been equipped by the DZHK are solely for the examination of patients participating in...

Congenital heart defects (CHD) are severe chronic diseases. Yet most patients with chronic heart disease aged between ten and thirty assess their own health as good to very good. Moreover, they barely feel impaired in their everyday lives. Only very few patients make use of...

The German Centre for Cardiovascular Disease (DZHK) has announced a new €12 million partnership with the British Heart Foundation, to fund ground-breaking research and foster international collaboration.

The outcome of viral myocarditis is closely associated with the immune response of the affected individual. An inhibitor of the immunoproteasome, a protein degradation complex in immunocompetent cells, reduces the extent of the inflammation and thus also the damage to the heart...